Mao, L. et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 77(6), 683–690 (2020).
Google Scholar
Frithiof, R. et al. Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients: A prospective study. Clin. Neurophysiol. 132(7), 1733–1740 (2021).
Google Scholar
Datta, S. D., Talwar, A. & Lee, J. T. A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: Illness beyond acute infection and public health implications. JAMA 324(22), 2251–2252 (2020).
Google Scholar
Carfi, A., Bernabei, R. & Landi, F. Gemelli against C-P-ACSG: Persistent symptoms in patients after acute COVID-19. JAMA 324(6), 603–605 (2020).
Google Scholar
Nalbandian, A. et al. Post-acute COVID-19 syndrome. Nat. Med. 27(4), 601–615 (2021).
Google Scholar
Townsend, L. et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE 15(11), e0240784 (2020).
Google Scholar
Huang, C. et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet 397(10270), 220–232 (2021).
Google Scholar
van den Borst, B. et al. Comprehensive health assessment 3 months after recovery from acute coronavirus disease 2019 (COVID-19). Clin. Infect. Dis. 73(5), e1089–e1098 (2021).
Google Scholar
Writing Committee for the CSG, Morin, L., Savale, L., Pham, T., Colle, R., Figueiredo, S., Harrois, A., Gasnier, M., Lecoq, A. L. & Meyrignac, O. et al. Four-month clinical status of a cohort of patients after hospitalization for COVID-19. JAMA 2021, 325(15):1525–1534.
Frontera, J. A. et al. A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications. J. Neurol. Sci. 426, 117486 (2021).
Google Scholar
Needham, D. M. et al. Improving long-term outcomes after discharge from intensive care unit: Report from a stakeholders’ conference. Crit. Care Med. 40(2), 502–509 (2012).
Google Scholar
Marra, A. et al. Co-occurrence of post-intensive care syndrome problems among 406 survivors of critical illness. Crit. Care Med. 46(9), 1393–1401 (2018).
Google Scholar
Pekny, M. & Nilsson, M. Astrocyte activation and reactive gliosis. Glia 50(4), 427–434 (2005).
Google Scholar
Khalil, M. et al. Neurofilaments as biomarkers in neurological disorders. Nat. Rev. Neurol. 14(10), 577–589 (2018).
Google Scholar
Wang, Y. & Mandelkow, E. Tau in physiology and pathology. Nat. Rev. Neurosci. 17(1), 5–21 (2016).
Google Scholar
Prudencio, M. et al. Serum neurofilament light protein correlates with unfavorable clinical outcomes in hospitalized patients with COVID-19. Sci. Transl. Med. 13(602), eabi7643 (2021).
Google Scholar
Sutter, R. et al. Serum neurofilament light chain levels in the intensive care unit: Comparison between severely ill patients with and without coronavirus disease 2019. Ann. Neurol. 89(3), 610–616 (2021).
Google Scholar
Kanberg, N. et al. Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19. Neurology 95(12), e1754–e1759 (2020).
Google Scholar
Kanberg, N. et al. Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up. EBioMedicine 70, 103512 (2021).
Google Scholar
Metnitz, P. G. et al. SAPS 3–From evaluation of the patient to evaluation of the intensive care unit Part 1: Objectives, methods and cohort description. Intensive Care Med. 31(10), 1336–1344 (2005).
Google Scholar
Smets, E. M., Garssen, B., Bonke, B. & De Haes, J. C. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J. Psychosom. Res. 39(3), 315–325 (1995).
Google Scholar
Nasreddine, Z. S. et al. The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 53(4), 695–699 (2005).
Google Scholar
Kato, H. et al. Immunocytochemical characterization of supporting cells in the enteric nervous system in Hirschsprung’s disease. J. Pediatr. Surg. 25(5), 514–519 (1990).
Google Scholar
Bianchini, D. et al. GFAP expression of human Schwann cells in tissue culture. Brain Res. 570(1–2), 209–217 (1992).
Google Scholar
Hainfellner, J. A. et al. Fibroblasts can express glial fibrillary acidic protein (GFAP) in vivo. J. Neuropathol. Exp. Neurol. 60(5), 449–461 (2001).
Google Scholar
Middeldorp, J. & Hol, E. M. GFAP in health and disease. Prog. Neurobiol. 93(3), 421–443 (2011).
Google Scholar
Eng, L. F., Ghirnikar, R. S. & Lee, Y. L. Glial fibrillary acidic protein: GFAP-thirty-one years (1969–2000). Neurochem. Res. 25(9–10), 1439–1451 (2000).
Google Scholar
Morgan, T. E. et al. The mosaic of brain glial hyperactivity during normal ageing and its attenuation by food restriction. Neuroscience 89(3), 687–699 (1999).
Google Scholar
Nichols, N. R., Day, J. R., Laping, N. J., Johnson, S. A. & Finch, C. E. GFAP mRNA increases with age in rat and human brain. Neurobiol. Aging 14(5), 421–429 (1993).
Google Scholar
Oeckl, P. et al. Glial fibrillary acidic protein in serum is increased in Alzheimer’s disease and correlates with cognitive impairment. J. Alzheimers Dis. 67(2), 481–488 (2019).
Google Scholar
Rudroff, T., Workman, C. D. & Bryant, A. D. Potential factors that contribute to post-COVID-19 fatigue in women. Brain Sci. 12(5), 556 (2022).
Google Scholar
Virhammar, J. et al. Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID-19 and associated with neurological symptoms and disease severity. Eur. J. Neurol. 28(10), 3324–3331 (2021).
Google Scholar
Wintermann, G. B. et al. Self-reported fatigue following intensive care of chronically critically ill patients: A prospective cohort study. J. Intensive Care 6, 27 (2018).
Google Scholar
Davis, D. H. et al. Montreal cognitive assessment for the diagnosis of Alzheimer’s disease and other dementias. Cochrane Database Syst. Rev. 2015(10), CD010775 (2015).
Google Scholar
Moseby-Knappe, M. et al. Serum neurofilament light chain for prognosis of outcome after cardiac arrest. JAMA Neurol. 76(1), 64–71 (2019).
Google Scholar
Tiedt, S. et al. Serum neurofilament light: A biomarker of neuroaxonal injury after ischemic stroke. Neurology 91(14), e1338–e1347 (2018).
Google Scholar
Gendron, T. F. et al. Plasma neurofilament light predicts mortality in patients with stroke. Sci. Transl. Med. 12(569), eaay1913 (2020).
Google Scholar
Shahim, P. et al. Serum neurofilament light protein predicts clinical outcome in traumatic brain injury. Sci. Rep. 6, 36791 (2016).
Google Scholar
Fong, T. G. et al. Association of plasma neurofilament light with postoperative delirium. Ann. Neurol. 88(5), 984–994 (2020).
Google Scholar
Shahim, P. et al. Blood biomarkers for brain injury in concussed professional ice hockey players. JAMA Neurol. 71(6), 684–692 (2014).
Google Scholar
Shahim, P., Tegner, Y., Marklund, N., Blennow, K. & Zetterberg, H. Neurofilament light and tau as blood biomarkers for sports-related concussion. Neurology 90(20), e1780–e1788 (2018).
Google Scholar
Girard, T. D., Dittus, R. S. & Ely, E. W. Critical illness brain injury. Annu. Rev. Med. 67, 497–513 (2016).
Google Scholar
Mikkelsen, M. E. et al. The adult respiratory distress syndrome cognitive outcomes study: Long-term neuropsychological function in survivors of acute lung injury. Am. J. Respir. Crit. Care Med. 185(12), 1307–1315 (2012).
Google Scholar
Hopkins, R. O. et al. Neuropsychological sequelae and impaired health status in survivors of severe acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 160(1), 50–56 (1999).
Google Scholar
Harvey, M. A. & Davidson, J. E. Postintensive care syndrome: Right care, right now…and later. Crit. Care Med. 44(2), 381–385 (2016).
Google Scholar
Herridge, M. S. et al. Recovery and outcomes after the acute respiratory distress syndrome (ARDS) in patients and their family caregivers. Intensive Care Med. 42(5), 725–738 (2016).
Google Scholar
Wilcox, M. E. et al. Cognitive dysfunction in ICU patients: Risk factors, predictors, and rehabilitation interventions. Crit Care Med. 41(9 Suppl 1), S81-98 (2013).
Google Scholar
Jackson, J. C. et al. Six-month neuropsychological outcome of medical intensive care unit patients. Crit Care Med. 31(4), 1226–1234 (2003).
Google Scholar
